Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dudley

Showing results (191-200 of 226) with videos related to

Pageof 23
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2012
Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?Adham S Bear, Richard A Morgan, Kenneth Cornetta, et al.
Blood|July 30, 2010
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N Kochenderfer, Wyndham H Wilson, John E Janik, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 19, 2012
Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanomaBradley J Seaman, Elizabeth A Guardiani, Carmen C Brewer, et al.
Science Translational Medicine|August 31, 2012
The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humansAnran Wang, Smita Chandran, Syed A Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
British Journal of Cancer|October 17, 2013
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2D Bedognetti, T L Spivey, Y Zhao, et al.
Pageof 23

Showing results (191-200 of 226) with videos related to

Sort By:
Pageof 23
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2012
Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?Adham S Bear, Richard A Morgan, Kenneth Cornetta, et al.
Blood|July 30, 2010
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N Kochenderfer, Wyndham H Wilson, John E Janik, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 19, 2012
Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanomaBradley J Seaman, Elizabeth A Guardiani, Carmen C Brewer, et al.
Science Translational Medicine|August 31, 2012
The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humansAnran Wang, Smita Chandran, Syed A Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
British Journal of Cancer|October 17, 2013
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2D Bedognetti, T L Spivey, Y Zhao, et al.
Pageof 23